Advertisement

HCPLive Year in Review: Top Podcasts & Shows for 2024

Published on: 

From groundbreaking therapies to ethical dilemmas, HCPLive’s top podcasts of 2024 delivered expert insights and human stories across medicine.

This year, HCPLive podcasts and shows continued to deliver cutting-edge insights on the most pressing topics in healthcare. From thought-provoking discussions on the latest medical advancements and clinical breakthroughs to perspectives on pressing healthcare issues, these episodes brought the forefront of medicine to listeners everywhere.

Our hosts and guests tackled topics both cutting-edge and deeply human, from the future of automated insulin delivery systems for type 1 diabetes (T1D) to dissecting ethical dilemmas in medically assisted suicide. Truly, the diverse lineup of episodes offered something for every corner of the medical community, from the role of finerenone in heart failure, an analysis into the groundbreaking potential of semaglutide for nondiabetic kidney disease, or reflecting on the 60th anniversary of the landmark Surgeon General's report on smoking.

Here are a few standout episodes where our hosts explored breakthroughs, challenges, and personal stories across specialties, capturing the year’s pivotal moments in healthcare.

Diabetes Dialogue

Diabetes Dialogue: What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD

The diabetes community welcomed an additional tool to their armamentarium with the US Food and Drug Administration (FDA)’s clearance of Sequel Med Tech’s twiist automated insulin delivery (AID) system in March 2024. Cleared for use in patients aged ≥6 years with type 1 diabetes (T1D), the twiist is billed as the first drug delivery system that directly measures volume and flow of inulin delivered with every micro-dose.

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, Alan Lotvin, MD, chief executive officer and co-founder of Sequel Med Tech joins hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, for a deep dive into the latest AID to receive approval, including the pump’s patient-centric design, why they chose to leverage the Tidepool Loop algorithm, plans for device launch, and more.

Don’t Miss a Beat

Don't Miss a Beat: Finerenone's Role in Heart Failure from ESC Congress Data

In this edition of Don’t Miss a Beat at the European Society of Cardiology (ESC) Congress 2024, Stephen Greene, MD, an advanced heart failure specialist at Duke University School of Medicine, discusses the prospect of finerenone (Kerendia) in treatment algorithms for heart failure with Muthiah Vaduganathan, MD, MPH, codirector of the Center for Cardiometabolic Implementation Science of Brigham and Women’s Hospital, who served as an investigator on the FINEARTS-HF trial and presenter of FINE-HEART.

Kidney Compass

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024

In this episode of Kidney Compass: Navigating Clinical Trials, hosts Brendon Neuen, MBBS, PhD, nephrologist and director of the Kidney Trials Unit at Royal North Shore Hospital and senior research fellow at The George Institute for Global Health, and Shikha Wadhwani, MD, MS, director of clinical trials in the Division of Nephrology and the vice chair of clinical research in the Department of Medicine at the University of Texas Medical Branch, hosted Hiddo Heerspink, PhD, PharmD, of the University of Groningen, after he presented the landmark SMART trial at the American Society of Nephrology’s Kidney Week 2024, which suggested the benefit of semaglutide 2.4 mg (Ozempic/Wegovy) on chronic kidney disease (CKD) extend to patients without diabetes.

Lungcast

Reflecting on the 1964 Surgeon General Report with Viet Le, DMSc, PA-C

US Public Health Service Surgeon General Luther L. Terry, MD, presented a report on January 11, 1964, which altered the future of US public health policy and practice and kickstarted the ever-evolving regulation of tobacco products. In honor of the 60th anniversary of the Surgeon General’s report, a special Lungcast saw Al Rizzo, MD, chief medical officer of the ALA host a a discussion with Viet Le, DMSc, PA-C, an associate professor of research and preventive cardiology PA at Intermountain Heart and Vascular, dedicated to the clinical and public health significance of the report—and how its intent reverberates in modern clashes with the vaping industry.

Medical Ethics Unpacked

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

In this episode of Medical Ethics Unpacked, hosts Steve Levine, MD, a psychiatrist, and Dominic Sisti, PhD, a bioethicist, begin a 2-part discussion examining medically-assisted suicide, often referred to as medical assistance in dying (MAID), and euthanasia, particularly in the context of severe psychiatric conditions. The first part of the discussion focuses on foundational concepts and the broader context of MAID, laying the groundwork for an in-depth ethical discussion.

New Insight

New Insight: A Look at Gildeuretinol (ALK-001) for Stargardt Disease w/ Seemi Khan, MD

Recent years have proven the robustness of the ophthalmic pipeline, and what’s coming down the pike could be some of the most impressive agents ever introduced to eye care. Stargardt disease affects nearly 30,000 people in the US and more than 150,000 worldwide, with no currently approved therapy.

In this episode of New Insight with Veeral Sheth, MD, host Veeral Sheth, MD, director of clinical research at University Retina, speaks with Seemi Khan, chief medical officer at Alkeus Pharmaceuticals, on the company’s lead candidate, gildeuretinol (ALK-001), being evaluated in clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

The APAC Recap

The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C

In this episode of The APAC Recap, host Laura Ross, PA-C, president of the Academy of Physician Associates in Cardiology (APAC), is joined by Bob Ross, PA-C, chair of APAC’s vascular medicine committee and a leading expert in peripheral arterial disease (PAD), to discuss updates on PAD from the inaugural CAPP Live 2024 conference. The discussion centered on recent updates in PAD diagnosis and management, including key takeaways from Ross’ conference presentation, which highlighted symptoms and risk factors for PAD based on new guidelines from the American College of Cardiology and the American Heart Association.

The Medical Sisterhood

The Medical Sisterhood: Motherhood in Medicine, with Alexandra Golant, MD

In this episode of The Medical Sisterhood, host Mona Shahriari, MD, is joined by Alexandra Golant, MD, medical director of the Dermatology Faculty Practice and the program director of the Dermatology Residency Program at Mount Sinai, to discuss the complexities of balancing motherhood and a medical career. Golant, who also serves as an assistant clinical professor in the Department of Dermatology at Mount Sinai, shares her journey in medicine, the challenges of raising 4 children, and the importance of accepting imperfection in both personal and professional roles.


Advertisement
Advertisement